Anti ischaemic efficacy of amlodipine vs nifedipine in the treatment of patients with stable exertional angina

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 113-118

  Pandolfo, Luciano ^a   Pajes, Giuseppe ^a   Zardi, Domenico ^a   Giorgi, Gabriele ^a,b  

^a 'S Sebastiano M' Hospital   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ADULT; AGED; ANGINA PECTORIS; ANKLE EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE; VERTIGO;

EID: 0030842377     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00020     Document Type: Article

References (18)

1. Burges RA, Gardiner DG, Gwilt M, et al. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors. J Cardiovasc Pharmacol 1987; 9: 110-9
2. Lund-Johansen P, Omvik P, White W, et al. Long term haemodynamics effects of amlodipine at rest and during exercise in essential hypertension. J Hypertens 1990; 8: 1129-36
3. Mroczeck WJ, Burris JF, Allenby KS. A double blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: 579-84
4. Heber ME, Brigden G, Al Khawaja I, et al. 24h blood pressure control with the once daily calcium antagonist, amlodipine. Br J Clin Pharmacol 1989; 27: 359-65
5. Webster J, Robb OJ, Jeffers TA, et al. Once-daily amlodipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: 72-5
6. Frick MH, McGibney D, Tyler HM. A dose response study of amlodipine in mild to moderate hypertension. J Int Med 1989; 225: 101-5
7. Kinnard DR, Harris M, Hossack KF. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S110-3
8. Taylor SH, Lee P, Jackson N, et al. A double blind, placebo controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris. J Cardiovasc Pharmacol 1991; 17 Suppl. 1: 46-9
9. Beckerman B. An open multicenter efficacy and safety evaluation of amlodipine in the treatment of symptomatic myocardial ischemia. J Cardiovasc Pharmacol 1991; 17: S61-4
10. Faulkner JK, McGibney D, Chausseaud LF, et al. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated doses given once daily. Br J Clin Pharmacol 1986; 22: 21-5
11. Williams DM, Cubeddu LX. Amlodipine pharmacokinetics in healthy volunteers. J Clin Pharmacol 1988; 28: 900-4
12. Maseri A, Chiercha S, Kaski JC. Mixed angina pectoris. Am J Cardiol 1985; 56: 3IE
13. Brown BJ, Ball RM, Cobb FR, et al. The mechanism of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 1981; 64: 1089
14. Brown BG, Bolson EL, Dodge HT. Dynamic mechanisms in human coronary stenosis. Circulation 1984; 70: 917-21
15. Chanine RA, Feldman RL, Giles TD, et al. Randomised placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993; 21: 1365-70
16. Perondi R, Saino A, Lanchetti A, et al. Coronary vascular reactivity and calcium antagonist therapy in patients with angina. J Cardiovasc Pharmacol 1994; 24 Suppl. A: S30-6
17. Gross GJ, Farber NE, Pieper GM. Effects of amlodipine on myocardial ischemia-reperfusion injury in dogs. Am J Cardiol 1989; 64: 94-1001
18. Rafflenbeul W, Lichtlen PR. Release of residual vascular tone in coronary artery stenoses with nifedipine and glyceril trinitrate. In: Kaltenbach H, Neufeld HN, editors. 5th International Adalat Symposium; 1983; Amsterdam: Excerpta Medica: 300